Skip to main content
OpenTrials

Clinical trial condition

Dementia

Explore clinical trials studying Dementia. Study availability and eligibility vary by location and protocol.

2,729 public trials 505 recruiting studies
Refine in advanced search Browse all conditions

Dementia trial results

Recruiting

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7812653 in Participants With Early Symptomatic Alzheimer's Disease (eAD)

NCT07234942

Conditions
Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
Locations
  • Montreal Neurological Institute Clinical Research Unit Montreal, Quebec, Canada
  • Brain Research Center Amsterdam Amsterdam, North Holland, Netherlands
  • Hospital de la Santa Creu i Sant Pau Barcelona, Spain
  • Hospital Universitario Reina Sofia Córdoba, Spain
View Trial Details
Recruiting

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

NCT06563895

Conditions
Alzheimer Disease, Amyloid Cardiomyopathy, Amyloid Neuropathies, +26 more
Locations
  • University of California, San Diego (UCSD) - Medical Center La Jolla, California, United States
  • University of California, Los Angeles (UCLA) - David Geffen School of Medicine Los Angeles, California, United States
  • University of California, San Francisco (UCSF) San Francisco, California, United States
  • Stanford University Stanford, California, United States
View all 103 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RG6496 in Huntington's Disease

NCT07246941

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
Locations
  • Hospital Britanico de Buenos Aires Ciudad Autonoma Bs As, Argentina
  • Westmead Hospital Westmead, New South Wales, Australia
  • Monash Health Clayton, Victoria, Australia
  • Royal Melbourne Hospital Parkville, Victoria, Australia
View Trial Details
Recruiting

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2)

NCT07011745

Conditions
Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • Chandler Clinical Trials, LLC Chandler, Arizona, United States
  • Local Institution - 2631 Chandler, Arizona, United States
  • Local Institution - 2646 Chandler, Arizona, United States
  • National Institute of Clinical Research Garden Grove, California, United States
View all 145 locations
View Trial Details

Related conditions